Skip to content

Global Advocacy

Advocating at the global level to achieve cardiovascular health for everyone

Priority Areas

Universal Health Coverage (UHC)

Advocating for fiscal policies, including taxes on tobacco, alcohol and sugar-sweetened beverages, to help fund UHC.

Learn more

Air Pollution

Air pollution is a significant risk factor for CVD and as such must urgently be addressed through research, education, and policy change.

Learn more

Rheumatic Heart Disease (RHD)

RHD is a preventable, treatable form of cardiovascular disease that affects over 33 million people around the world, chiefly in low-resource settings.

Learn more

Tobacco

As smoking prevalence continues to climb in the developing world, we are mobilizing the CVD community in the fight against tobacco.

Learn more

Advocating at the UN

World Health Organization

WHF is the only organization representing the CVD community in Official Relations with the WHO, the global authority on public health policy.

Learn more

United Nations

Our advocacy experts work closely with the UN, its agencies, and other international bodies to influence global policies, strategies and funding.

Learn more

Committees and Expert Groups

Advocacy Committee

This Committee is composed of experts representing each WHO Region. It serves to inform and approve science-based policy proposals.

Learn more

Tobacco Expert Group (TEG)

The TEG supports the development of WHF position papers, external statements, and internal policies to advance progress on global tobacco control.

Learn more

Air Pollution Expert Group (APEG)

The APEG guides the work of WHF in the area of air pollution and CVD, identifying areas for further research and prioritizing key advocacy objectives.

Learn more

Global Coalition for Circulatory Health

Uniting for Circulatory Health

The Global Coalition for Circulatory Health brings together international, regional and national stakeholders in circulatory health.

Learn more

WHF Advocacy Strategy 2019-22

Latest News

Addressing Noncommunicable Diseases at WHA75

This is a statement made at the 75th World Health Assembly (22-28 May 2022) on Agenda Item 14.1: Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases; Annex A: Draft implementation road map 2023–2030 for the global action plan for the prevention […]

Addressing Emergency Preparedness at WHA75

This is a statement made at the 75th World Health Assembly (22-28 May 2022) on Agenda Item 16.2: Strengthening WHO preparedness for and response to health emergencies.   Honourable Chair, Distinguished Delegates, People living with circulatory conditions are disproportionately impacted by the COVID-19 pandemic. The lack of attention to NCDs in the early stages of […]

World Hypertension Day: Taking action against the silent epidemic of high blood pressure

Hypertension is the leading preventable risk factor for cardiovascular disease. It affects an estimated 1.3 billion worldwide, killing approximately 10 million people every year. Low and middle-income countries have seen a growing prevalence of hypertension in recent years, with many countries having to deal with the double burden of communicable and non-communicable diseases. In Sub-Saharan […]

Hypertension

Discussing public health emergency preparedness at #EB150

This is a statement made at the 150th Executive Board Meeting of the World Health Organization on Agenda Item 15.3: WHO’s work in health emergencies  Honourable Chair, Distinguished Delegates, People living with circulatory conditions are disproportionately impacted by the COVID-19 pandemic. The lack of attention to NCDs in the early stages of the pandemic impeded […]